Brain Networks Responsible for Sense of Agency

Brain Networks Responsible for Sense of Agency: An EEG Study

This study of healthy normal volunteers will examine the brain networks involved in people's sense that they control their own movements (sense of agency). Although almost everyone has a sense of agency, some patients (for example, patients with schizophrenia, alien limb phenomena, and others) have movements they think are not under their control. This study will use electroencephalography (EEG) to determine how the normal brain produces the sense of agency. This information will provide a first step in understanding patients with an impaired sense of agency.

Healthy, right-handed men and women 18 years of age and older may be eligible for this study. Candidates are screened with a medical history and neurological examination.

Participants are fitted with a cyberglove device (a lightweight glove with flexible sensors that measure the position and movement of the fingers and wrist) on their right hand. The glove is used to transform the subject's hand and finger motions into real-time digital joint-angle information. Subjects slowly open and close their hand while watching an artificial hand projected on a monitor. They continue practicing the exercise until they are comfortable with the cyberglove and have the sense that the artificial hand is a mirror representation of their own hand, accurately reflecting their hand's movements.

After practicing with the cyberglove, subjects have a functional EEG. For this test, electrodes are placed on the scalp, and brain waves are recorded while the subject opens and closes his or her hand or just watches the computer monitor. The EEG recording takes about 60 minutes.

...

Study Overview

Status

Completed

Detailed Description

Objective

The purpose of this study is to investigate spatiotemporal patterns of brain networks involved in the sense of agency using high-resolution electroencephalography (EEG).

Study Population

We intend to use 20 right-hand dominant, adult healthy subjects.

Design

The sense of agency (SA) will be modulated using a visual task-based stimulus asking subjects to manipulate the position of an artificial hand projected onto a display. Subjects will use their own right hand to make slow opening/closing movements randomly which will be represented visually with the aid of a Cyberglove. During a behavioral training phase, subjects will practice using the apparatus. The level of control will be randomly changed to one of five states: 100%, 75%, 50%, 25%, 0% control. For secondary analysis, subjects will be asked to report the percentage of control they subjectively feel over the displayed hand. After subjects are comfortable with the apparatus and endorse SA over the displayed hand, they will undergo EEG.

The experimental phase will have five sets of 10 minute recording sessions where the subject is instructed to slowly open and close their hand randomly. The level of control will be changed pseudo-randomly throughout the recording sessions. A control contrast consisting of the subject observing a moving hand will also be integrated into the blocks. An additional control contrast involving the subject moving their hand without visual feedback will also be included. These contrasts will serve in the analysis phase to help eliminate electrophysiological activity related to visual-motor feedback.

A Magnetic Resonance Imaging (MRI) scan of brain will be performed to co-register this EEG data with the anatomical structure. We will integrate physiological (EEG) and anatomical (MRI) data to characterize the regionalization of the task-related brain EEG activity.

Outcome Measures

The primary outcome of this study is the effective connectivity of brain in response to a loss of SA. For this purpose, we will measure the difference of EEG power spectral analysis as well as coherence between 0% and 100 % control. In a secondary analysis, we will investigate the correlation of the EEG measurements with the percent of actual control, and also utilize the individual subject perceptions of percent control during the behavioral training phase as the regressors for activation rather than the objective control settings.

Study Type

Observational

Enrollment

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Bethesda, Maryland, United States, 20892
        • National Institutes of Health Clinical Center, 9000 Rockville Pike

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

  • INCLUSION CRITERIA:

Subjects age 18 and older

Subjects must be right-hand dominant (Edinburgh Handedness Quotient greater than 60)

Subjects willing to abstain from caffeine or alcohol for 48 hours prior to the EEG study

EXCLUSION CRITERIA:

Subjects with any abnormal findings on neurological exam

Subjects with any history of brain tumor, stroke, head trauma or a vascular malformation as obtained by history or from imaging studies

Subjects with any history of a severe medical condition, such as cardiovascular disease, which would prevent them from sitting for up to 120 minutes

Subjects without the capacity to give informed consent

Subjects with other restrictions which prevent them from undergoing EEG recordings for up to 60 minutes

Subjects who are taking neuroleptic medications

Subjects are not eligible for Magnetic Resonance Imaging (MRI) scan, if the subjects have pacemakers, intracardiac line, implanted metallic pump, neural stimulator, or a metallic object inside the skull, metal braces, cochlear devices, surgical clips and other metal/magnetic implants; are afraid of being in small spaces; are pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 27, 2006

Study Completion

December 16, 2008

Study Registration Dates

First Submitted

January 29, 2006

First Submitted That Met QC Criteria

January 28, 2006

First Posted (Estimate)

January 30, 2006

Study Record Updates

Last Update Posted (Actual)

July 2, 2017

Last Update Submitted That Met QC Criteria

June 30, 2017

Last Verified

December 16, 2008

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spatiotemporal Patterns

3
Subscribe